Clinical Trial Shows Combination Drug Treatment Lowers Death Risk by 21% in HIV-Related Fungal Disease

A clinical trial conducted by City St George's, University of London, found that adults with HIV-related cryptococcal disease treated with a two-drug combination had a 21% lower risk of dying compared to those treated with a single drug. This new approach explored using the combination earlier, before meningitis sets in.